White Paper:

Summary of Blue Matter “Breakfast Club” Meeting No. 7: Artificial Intelligence (AI) in Pharmaceuticals

The Blue Matter Breakfast Club is an ongoing series of discussion forums, now virtual due to COVID-19, hosted by our team in Europe.  These forums are by invitation, bringing together leading executives from biopharma companies and other organizations to discuss critical business issues.

The seventh Breakfast Club meeting took place on 16 December 2020.  The guest speaker was Gisbert Schneider, Full Professor of Computer-Assisted Drug Design (and world-leading expert on applied AI), ETH Zurich

The key topics centered around AI concepts, the use of AI in drug design, and the future potential application of AI in the pharmaceutical industry.

  • Hidden
  • This field is for validation purposes and should be left unchanged.